With launches on the way in the US and EU, MC2 turns attention to the rest of its pipeline
![Photo: MC2 Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13129128.ece/ALTERNATES/schema-16_9/doc7gmz1xagjl117p3ve2k5.jpg)
The launch of psoriasis drug Wyzora alongside Epi Health marks the beginning of a new era for MC2 Therapeutics.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.